Vogelxo Approval History
- FDA approved: Yes (First approved June 4th, 2014)
- Brand name: Vogelxo
- Generic name: testosterone
- Dosage form: Transdermal Gel
- Company: Upsher-Smith Laboratories Inc.
- Treatment for: Hypogonadism, Male
Vogelxo (testosterone) transdermal gel is an androgen indicated for testosterone replacement therapy in males with hypogonadism.
Development History and FDA Approval Process for Vogelxo
|Jun 5, 2014||Upsher-Smith Receives Final NDA Approval For Vogelxo (testosterone) Gel|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.